XueBiJing Injection Versus Placebo for Critically Ill Patients With Severe Community-Acquired Pneumonia: A Randomized Controlled Trial

OBJECTIVES: To investigate whether XueBiJing injection improves clinical outcomes in critically ill patients with severe community-acquired pneumonia. DESIGN: Prospective, randomized, controlled study. SETTING: Thirty-three hospitals in China. PATIENTS: A total of 710 adults 18–75 years old with sev...

詳細記述

保存先:
書誌詳細
出版年:Crit Care Med
主要な著者: Song, Yuanlin, Yao, Chen, Yao, Yongming, Han, Hui, Zhao, Xiaodong, Yu, Kaijiang, Liu, Luyi, Xu, Ying, Liu, Zhongmin, Zhou, Qingshan, Wang, Ying, Ma, Zhuang, Zheng, Youguang, Wu, Dawei, Tang, Zhongzhi, Zhang, Minzhou, Pan, Shuming, Chai, Yanfen, Song, Yan, Zhang, Jian, Pan, Lei, Liu, Yi, Yu, He, Yu, Xuezhong, Zhang, Hong, Wang, Xiaoge, Du, Zhaohui, Wan, Xianyao, Tang, Yijun, Tian, Yingping, Zhu, Yimin, Wang, Hongliang, Yan, Xiaoyan, Liu, Zhi, Zhang, Boli, Zhong, Nanshan, Shang, Hongcai, Bai, Chunxue
フォーマット: Artigo
言語:Inglês
出版事項: Lippincott Williams & Wilkins 2019
主題:
Online Clinical Investigations
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6727951/
https://ncbi.nlm.nih.gov/pubmed/31162191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCM.0000000000003842
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料